Jefferies Lifts Numbers on HCA (HCA), Could Be Seeing Early Stages of a Recovery

FREE Breaking News Alerts from StreetInsider.com!

HCA Hot Sheet

Rating Summary:
21 Buy, 5 Hold, 0 Sell

Rating Trend:

Up

Today's Overall Ratings:
Up: 20 | Down: 11 | New: 38

Jefferies raised estimates and its price target HCA Holdings (NYSE: HCA) from $30 to $34, while reiterating a Buy rating.

The firm comments, "We could be in the early stages of a recovery in healthcare service utilization. If this is true, HCA, long considered the bellwether of the sector, is well positioned to outperform given its depressed valuation. HCA's dynamic cash flows could be harnessed to drive upside performance. Reiterate Buy/$34PT (from $30)."

Jefferies raised Q1 EPS form $0.80 to $0.94 and FY12 from $2.64 to $2.93.

For an analyst ratings summary and ratings history on HCA Holdings click here. For more ratings news on HCA Holdings click here.

Shares of HCA Holdings closed at $27.80 yesterday, with a 52 week range of $17.03-$35.37.

Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!